Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The physical barrier of the nasal mucosa is composed primarily of tightly connected epithelial cells, forming a continuous cellular lining that separates the external environment from submucosal tissues[1][2][4][6]. This barrier functions by preventing allergens, pathogens, and particulates from infiltrating deeper tissues, supported by specialized structures like tight junctions, adherens junctions, and desmosomes[1][2]. The barrier works together with mucus (chemical barrier), immune structures (immune barrier), and microbiota (microbiological barrier) to provide layered protection for the respiratory tract[1][2][6]. Dysfunction or damage to this physical barrier can lead to increased susceptibility to allergic diseases, infections, and other inflammatory conditions[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical barrier of the nasal mucosa.